Mesa Historical Financial Ratios
MLAB Stock | USD 126.33 3.33 2.71% |
Mesa Laboratories is lately reporting on over 111 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Days Sales Outstanding of 84.73 will help investors to properly organize and evaluate Mesa Laboratories financial condition quickly.
Mesa |
About Mesa Financial Ratios Analysis
Mesa LaboratoriesFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Mesa Laboratories investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Mesa financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Mesa Laboratories history.
Mesa Laboratories Financial Ratios Chart
Add Fundamental
Dividend Yield
Dividend Yield is Mesa Laboratories dividend as a percentage of Mesa Laboratories stock price. Mesa Laboratories dividend yield is a measure of Mesa Laboratories stock productivity, which can be interpreted as interest rate earned on an Mesa Laboratories investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.Ptb Ratio
Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.Book Value Per Share
The ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements.Invested Capital
Invested capital represents the total cash investment that shareholders and debt holders have contributed to Mesa Laboratories. There are two different methods for calculating Mesa Laboratories invested capital: operating approach and financing approach. Understanding Mesa Laboratories invested capital allows investors to calculate measures of performance such as return on invested capital or return on capital employed.Most ratios from Mesa Laboratories' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Mesa Laboratories current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mesa Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For information on how to trade Mesa Stock refer to our How to Trade Mesa Stock guide.At present, Mesa Laboratories' Price To Sales Ratio is projected to increase slightly based on the last few years of reporting. The current year's Days Sales Outstanding is expected to grow to 84.73, whereas Dividend Yield is forecasted to decline to 0.01.
2021 | 2022 | 2023 | 2024 (projected) | Dividend Yield | 0.002513 | 0.003663 | 0.005714 | 0.005429 | Price To Sales Ratio | 7.21 | 4.24 | 2.79 | 2.94 |
Mesa Laboratories fundamentals Correlations
Click cells to compare fundamentals
Mesa Laboratories Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Mesa Laboratories fundamentals Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Price To Sales Ratio | 8.07 | 9.04 | 7.21 | 4.24 | 2.79 | 2.94 | |
Dividend Yield | 0.002867 | 0.002613 | 0.002513 | 0.003663 | 0.005714 | 0.005429 | |
Ptb Ratio | 4.32 | 2.98 | 3.37 | 2.36 | 4.15 | 2.35 | |
Days Sales Outstanding | 65.54 | 64.82 | 81.63 | 70.89 | 65.94 | 84.73 | |
Book Value Per Share | 52.38 | 81.65 | 75.56 | 73.95 | 26.99 | 28.34 | |
Operating Cash Flow Per Share | 6.32 | 7.45 | 7.53 | 5.26 | 8.19 | 8.6 | |
Stock Based Compensation To Revenue | 0.0469 | 0.0692 | 0.0618 | 0.0572 | 0.0552 | 0.0525 | |
Capex To Depreciation | 0.13 | 0.12 | 0.11 | 0.18 | 0.0813 | 0.0772 | |
Pb Ratio | 4.32 | 2.98 | 3.37 | 2.36 | 4.15 | 2.35 | |
Ev To Sales | 8.58 | 8.17 | 8.14 | 4.87 | 3.73 | 2.85 | |
Free Cash Flow Per Share | 5.97 | 7.05 | 6.68 | 4.4 | 7.72 | 8.1 | |
Roic | (0.005344) | (0.0133) | (0.0173) | 0.13 | (0.68) | (0.65) | |
Inventory Turnover | 3.71 | 4.2 | 3.06 | 2.46 | 2.54 | 1.8 | |
Net Income Per Share | 0.32 | 0.66 | 0.36 | 0.17 | (47.2) | (44.84) | |
Days Of Inventory On Hand | 98.46 | 86.95 | 119.36 | 148.08 | 143.8 | 211.22 | |
Payables Turnover | 15.48 | 10.49 | 9.53 | 13.92 | 13.73 | 20.82 | |
Research And Ddevelopement To Revenue | 0.054 | 0.0776 | 0.0855 | 0.0935 | 0.0893 | 0.0937 | |
Capex To Revenue | 0.0127 | 0.0149 | 0.024 | 0.0207 | 0.0119 | 0.0113 | |
Cash Per Share | 19.38 | 53.04 | 9.47 | 6.18 | 5.24 | 2.85 | |
Pocfratio | 35.75 | 32.68 | 33.87 | 33.23 | 13.67 | 14.66 | |
Payout Ratio | 2.02 | 0.97 | 1.78 | 3.66 | (0.0136) | (0.0129) | |
Capex To Operating Cash Flow | 0.0413 | 0.0564 | 0.0537 | 0.16 | 0.0582 | 0.0553 | |
Pfcf Ratio | 37.89 | 34.53 | 38.18 | 39.67 | 14.51 | 9.68 | |
Days Payables Outstanding | 23.58 | 34.79 | 38.31 | 26.22 | 26.59 | 17.9 | |
Income Quality | 19.69 | 11.32 | 20.96 | 30.09 | (0.17) | (0.16) | |
Roe | 0.006131 | 0.00806 | 0.004751 | 0.002364 | (1.75) | (1.66) | |
Ev To Operating Cash Flow | 38.01 | 29.52 | 38.25 | 38.13 | 18.27 | 14.63 | |
Pe Ratio | 703.91 | 370.01 | 710.01 | 999.72 | (2.37) | (2.25) | |
Return On Tangible Assets | 0.008495 | 0.009995 | 0.0113 | 0.002604 | (1.66) | (1.58) | |
Ev To Free Cash Flow | 40.28 | 31.19 | 43.12 | 45.53 | 19.4 | 20.37 | |
Earnings Yield | 0.001421 | 0.002703 | 0.001408 | 0.001 | (0.42) | (0.4) | |
Net Debt To E B I T D A | 7.42 | (9.48) | 5.77 | 3.77 | (0.85) | (0.81) | |
Current Ratio | 4.72 | 9.3 | 2.59 | 2.74 | 2.47 | 2.34 | |
Tangible Book Value Per Share | (9.86) | 26.86 | (28.3) | 16.69 | (27.56) | (26.18) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Mesa Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Mesa Laboratories' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Mesa Laboratories Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Mesa Laboratories Stock:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mesa Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For information on how to trade Mesa Stock refer to our How to Trade Mesa Stock guide.You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mesa Laboratories. If investors know Mesa will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mesa Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 3.875 | Dividend Share 0.64 | Earnings Share (45.62) | Revenue Per Share 42.3 | Quarterly Revenue Growth 0.088 |
The market value of Mesa Laboratories is measured differently than its book value, which is the value of Mesa that is recorded on the company's balance sheet. Investors also form their own opinion of Mesa Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Mesa Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mesa Laboratories' market value can be influenced by many factors that don't directly affect Mesa Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mesa Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if Mesa Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mesa Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.